Eli Lilly and Company opens new technology and innovation site in Hyderabad, India to enhance global operations.

A combination of lisocabtagene maraleucel (liso-cel, Breyanzi) plus ibrutinib (Imbruvica) demonstrated a trend for better ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...

Lilly has already onboarded 100 professionals at the Hyderabad facility and plans to expand the headcount to 1,500 over the ...

Telangana Chief Minister A Revanth Reddy inaugurated Eli Lilly’s new technology hub in Hyderabad, marking a significant leap ...

Eli Lilly and Company faces unexpected stock plunge despite strong growth, prompting caution and reflection among investors in the pharmaceutical sector.

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate ...

Eli Lilly and Company has opened a technology and innovation center in, India. This strategic hub, covering 2.2 lakh sqft, ...

Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

The pharmaceutical industry continues to evolve rapidly, driven by innovation, global health challenges, and technological ...